Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 20Sleep Initiation and Maintenance Disorders 6Anxiety Disorders 4Prostatic Neoplasms 3Weight Loss 2Overweight 2Obesity 2Motor Activity 2Melanoma 2Lung Neoplasms 2Depression 2Colorectal Neoplasms 2Weight Gain 1Uterine Cervical Neoplasms 1Smoking Cessation 1Pain, Postoperative 1Ovarian Neoplasms 1Neoplasms 1Medication Adherence 1Inflammation 1Genetic Predisposition to Disease 1Gastrointestinal Neoplasms 1Fanconi Anemia, Complementation Group D1 1Colonic Neoplasms 1Cognitive Dysfunction 1Chronic Pain 1

Interventions

Varenicline 1Nicotine Replacement Therapy 1Motivational Interviewing 1Hypnosis 1Ethanol 1Cognitive Behavioral Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Smoking Cessation × Cognitive Behavioral Therapy × Breast × Clear all
NCT04899492 2024-11-07

RESPIRE

Institut Cancerologie de l'Ouest

Phase NA Terminated
22 enrolled
BreastDermatologicGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Melanoma, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡